Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Hangzhou AGS MedTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,021	1,031	1,955	213.38	204.53	155.7
Short-Term Investments	54.22	81.2	-	-	-	-
Trading Asset Securities	665.52	671.22	82.42	55.01	1.09	-
Cash & Short-Term Investments	1,741	1,784	2,037	268.4	205.62	155.7
Cash Growth	-16.55%	-12.44%	659.01%	30.53%	32.06%	12.19%
Accounts Receivable	67.23	48.15	58.51	18.83	12.24	12
Other Receivables	1.39	0.79	1.18	2.11	2.04	2.03
Receivables	68.63	48.95	59.68	20.95	14.28	14.04
Inventory	65.87	56.38	46.8	38.57	39.89	20.01
Prepaid Expenses	-	-	0.05	0.1	-	0.18
Other Current Assets	4.96	5.42	2.45	3.88	2.78	3.2
Total Current Assets	1,880	1,894	2,146	331.89	262.56	193.12
Property, Plant & Equipment	197.18	200.09	159.7	117.67	54.89	41.32
Long-Term Investments	455.79	432.43	-	-	-	-
Other Intangible Assets	18.42	18.27	19	19.72	19.95	20.77
Long-Term Deferred Tax Assets	0.06	1.24	1.9	0.36	0.3	0.25
Long-Term Deferred Charges	5.29	2.77	2.35	3.3	3.18	3.64
Other Long-Term Assets	39.33	0.58	1.99	0.19	1.12	1.32
Total Assets	2,596	2,550	2,331	473.13	341.99	260.41
Accounts Payable	45.18	66.02	48.41	32.05	37.65	23.94
Accrued Expenses	29.56	40.84	34.79	24.29	9.13	11.57
Current Portion of Leases	1.39	1.3	0.57	1.08	0.94	-
Current Income Taxes Payable	11.94	17.49	14.95	15.7	6.95	1.67
Current Unearned Revenue	9.12	8.28	5.14	7.15	8.77	4.53
Other Current Liabilities	2.13	8.05	16.88	10.76	5.56	1.84
Total Current Liabilities	99.31	141.99	120.73	91.03	69	43.55
Long-Term Leases	1.19	2.15	-	0.57	1.39	-
Long-Term Unearned Revenue	7.84	8.53	2.1	-	-	0.17
Long-Term Deferred Tax Liabilities	-	-	-	-	0.16	-
Total Liabilities	108.35	152.67	122.83	91.59	70.55	43.72
Common Stock	81.12	80.98	57.87	43.4	43.4	43.4
Additional Paid-In Capital	1,721	1,725	1,715	76.53	76.53	76.53
Retained Earnings	687.68	621.87	434.79	261.54	151.62	96.82
Treasury Stock	-1.73	-30.97	-	-	-	-
Comprehensive Income & Other	0.53	0.1	0.11	0.07	-0.1	-0.06
Shareholders' Equity	2,488	2,397	2,208	381.54	271.45	216.69
Total Liabilities & Equity	2,596	2,550	2,331	473.13	341.99	260.41
Total Debt	2.58	3.45	0.57	1.64	2.32	-
Net Cash (Debt)	1,738	1,780	2,037	266.75	203.3	155.7
Net Cash Growth	-16.68%	-12.59%	663.48%	31.21%	30.57%	12.19%
Net Cash Per Share	21.47	22.09	28.06	4.39	3.35	2.56
Filing Date Shares Outstanding	81.36	80.58	81.02	60.76	60.76	60.76
Total Common Shares Outstanding	81.36	80.58	81.02	60.76	60.76	60.76
Working Capital	1,781	1,752	2,025	240.86	193.57	149.57
Book Value Per Share	30.58	29.75	27.26	6.28	4.47	3.57
Tangible Book Value	2,470	2,379	2,189	361.82	251.5	195.93
Tangible Book Value Per Share	30.35	29.52	27.02	5.95	4.14	3.22
Buildings	-	164.61	71.12	26.84	26.84	26.84
Machinery	-	52.19	41.56	7.7	28.88	20.29
Construction In Progress	-	8.65	67.92	72.65	10.55	4.63

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.